You may also like
Perfusion Partners Settles Patent Dispute With Cytomedix
Cytomedix (AMEX:GTF - News) today announced that Perfusion Partners and Associates Inc. (PPAI), based in Fort Meyers, Florida, and its affiliate organization, Transcorporeal Inc., have settled a patent dispute with Cytomedix for its platelet-derived therapies for treating wounds and other damaged tissue.
1 min read
Autologous Blood Management Strategies in Cardiac Surgery (EP Video)
In order to minimize the risks and adverse effects after transfusing homologous blood products, new strategies of autologous blood management (ABM) have been introduced in cardiac surgery (45:11 minutes).
1 min read
Long-Term Secondary Prevention of Acute Myocardial Infarction (SEPAT) – Guidelines Adherence and Outcome
This study evaluates prevention guideline adherence and outcome of guideline-directed secondary prevention in patients surviving 2 years after acute myocardial infarction (AMI).
1 min read